Currently out of the existing stock ratings of John Sourbeer, 35 are a BUY (49.3%), 35 are a HOLD (49.3%), 1 are a SELL (1.41%).

John Sourbeer

Work Performance Price Targets & Ratings Chart

Analyst John Sourbeer, currently employed at UBS, carries an average stock price target met ratio of 44.56% that have a potential upside of 8.84% achieved within 52 days.

John Sourbeer’s has documented 146 price targets and ratings displayed on 19 stocks. The coverage is on Healthcare, Industrials, Basic Materials sectors.

Most recent stock forecast was given on BRKR, Bruker at 01-Mar-2024.

Wall Street Analyst John Sourbeer

Analyst best performing recommendations are on OCDX (ORTHO CLINICAL DIAGNOSTICS HOLDINGS PLC).
The best stock recommendation documented was for OCDX (ORTHO CLINICAL DIAGNOSTICS HOLDINGS PLC) at 2/17/2022. The price target of $17 was fulfilled within 1 day with a profit of $0.83 (5.13%) receiving and performance score of 51.33.

Average potential price target upside

OCDX Ortho Clinical Diagnostics Holdings plc STVN Stevanato Group SpA TMO Thermo Fisher Scientific CYRX Cryoport IQV IQVIA Holdings OMIC Singular Genomics Systems MEDP Medpace Holdings ZY Zymergen BRKR Bruker CTLT Catalent QGEN Qiagen NV AKYA Akoya Biosciences ICLR ICON PLC MRVI Maravai Lifesciences Holdings  TXG 10X Genomics NSTG NanoString Technologies PACB Pacific Biosciences of California SYNH Syneos Health WST West Pharmaceutical Services

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Hold

18.19

$0.56 (3.18%)

24

2 years 2 months 9 days ago

0/2 (0%)

$0.83 (4.78%)

Hold

20

$2.37 (13.44%)

25

2 years 4 months 28 days ago

0/6 (0%)

$3.83 (23.69%)

Hold

17

$-0.63 (-3.57%)

28

2 years 4 months 28 days ago

1/3 (33.33%)

$0.83 (5.13%)

1

Buy

21

$3.37 (19.12%)

2 years 4 months 28 days ago

0/3 (0%)

$4.83 (29.87%)

Hold

24.68

$7.05 (39.99%)

24.68

2 years 6 months 14 days ago

0/2 (0%)

$3.29 (15.38%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

Which stock is John Sourbeer is most bullish on?

Potential upside of $52.02 has been obtained for WST (WEST PHARMACEUTICAL SERVICES)

Which stock is John Sourbeer is most reserved on?

Potential downside of $5.92 has been obtained for CTLT (CATALENT)

What Year was the first public recommendation made by John Sourbeer?

On 2020

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?